Navigation Links
YM BIOSCIENCES REPORTS FIRST QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS
Date:11/11/2007

The first US trial for AeroLEF(TM) has been cleared to proceed by the FDA and is pending clearance with the relevant Investigator Review Boards."

Nimotuzumab:

Nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR), is currently in varying stages of development in a number of trials, including colorectal cancer, adult and pediatric glioma, non-small-cell lung cancer and pancreatic cancer. During the first quarter of fiscal 2008:

- YM initiated enrollment for a Phase II colorectal cancer trial in

Canada. As of today, 30 patients have been enrolled in the first 50-

patient cohort, with recruitment of this cohort expected to be

completed by the end of calendar 2007 and data from this cohort are

expected to be reported in early calendar 2008. The endpoints of the

trial include Objective Response Rate (ORR), Progression Free

Survival (PFS), Overall Survival (OS) and the rates and durations of

Stable Disease (SD), as well as safety.

- YM USA was cleared by the US FDA to expand its second-line clinical

trial in children with DIPG into the US.

- YM reported positive preliminary results of a Phase I/II trial of

nimotuzumab in combination with radiation for the treatment of non-

small-cell lung cancer (NSCLC).

- Oncoscience AG reported completion of patient enrollment in the

Phase III, first-line, pediatric DIPG trial.

- Oncoscience AG reported initiation of late-stage trials designed to

be supportive of registration in adult glioma and pancreatic cancer.

- Subsequent to the end of the quarter:

- YM received clearance from Health Canada to extend into Canada the

188-patient multi-centre randomized, placebo controlled

Phase IIb/IIIa study in chemotherapy-naive patients with locally

advanced or metastatic pancreatic ca
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
2. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
3. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
4. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
5. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
6. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
7. Anaptys Biosciences Raises Over $33 Million in Series B Financing
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. Haemacure Reports Third Quarter 2007 Results
10. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... September 30, 2014(BRONX, NY)Medications are the leading cause of ... analysis of death certificates from 1999 to 2010, conducted ... and Albert Einstein College of Medicine of Yeshiva ... Journal of Allergy and Clinical Immunology , also ... was particularly high among older people and African-Americans and ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... as a free introduction to SurvivalLife.com along with a free ... caught the attention of Shane Michaels, prompting an investigative review. ... most well-known people in the survival and preparation niche, and ... all of the great classes and survival products that Joe ...
(Date:9/30/2014)... September 30, 2014 The American ... to help diabetics curb their sweet tooth, but the ... this September, suggests that zero-calorie sweeteners may actually ... diabetes. , The Weizmann Institute of Science in ... artificial sweeteners to mice, the mice developed glucose intolerance. ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Hospice ... its annual “In Celebration” gala, honoring three outstanding ... mission of striving to provide extraordinary and dignified ... facing a serious or life-limiting illness. , The ... in Rye, NY and recognized William (Bill) J. ...
(Date:9/30/2014)... 2014 A group of Americans is headed ... epidemic that, left unchecked, could create a catastrophic, global pandemic. ... to Africa. John Rogers, the Executive Director the Eugene Bell ... fight a disease most think mankind conquered long ago: tuberculosis. ... ago is on the comeback in several countries - what’s ...
Breaking Medicine News(10 mins):Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2
... Center at the University of California, San Diego, the University ... how a gene alteration can lead to the development of ... compound that could staunch the cancer,s growth. , The researchers, ... UC San Diego School of Medicine, have shown that when ...
... For decades, researchers have evaluated the thermal performance of ... current interest is how to address the burns received ... with fire - called stored heat burns. Researchers at ... and measurement protocol that allow firefighter suits to be ...
... to Enhance Tobacco-Related Research WASHINGTON, ... for Tobacco Research and Policy Studies at the ... Center at Georgetown University Medical Center ... Cancer Control Consortium. The consortium, formally agreed to ...
... nutritional benefits; Packaging now more environmentally responsibleNEW YORK, April ... the enhanced water category, PepsiCo (PEP) is re-launching ... beverage designed to help hydrate and nourish the body,s ... Propel is available in a variety of great-tasting ...
... findings at AMCP Conference in AprilST. PAUL, Minn., ... (Prime) revealed a significant reduction in inappropriate prescription ... drug utilization review (RetroDUR) program paired with a ... recently published in the American Journal of Geriatric ...
... recognition of April as National Autism Awareness Month, LoJack Corporation (Nasdaq: ... http://www.lojack.com/knowledge/Documents/AutismAwarenessMonth.mp3 ) that provided valuable information ... The rising incidence of autism in the ... of caring for an autistic child , ...
Cached Medicine News:Health News:Reversing effects of altered enzyme may fight brain tumor growth 2Health News:NC State develops new test method to measure stored heat in firefighter suits 2Health News:American Legacy Foundation(R) and Georgetown University Medical Center Create Research Collaboration 2Health News:American Legacy Foundation(R) and Georgetown University Medical Center Create Research Collaboration 3Health News:American Legacy Foundation(R) and Georgetown University Medical Center Create Research Collaboration 4Health News:Propel Unveils New Enhanced Experience 2Health News:Propel Unveils New Enhanced Experience 3Health News:Drug Utilization Review Reveals Potentially Inappropriate Medication Use Among Elderly Population 2Health News:Drug Utilization Review Reveals Potentially Inappropriate Medication Use Among Elderly Population 3Health News:April is National Autism Awareness Month: LoJack Hosts Educational Podcast Featuring Panel of Experts Addressing Autism Issues 2
(Date:9/30/2014)... , Sept. 30, 2014 A study using ... offered a new look at the composition of carotid ... physicians understand and treat the disease, a leading cause ... Baptist Health Lexington between September 2010 and May 2012, ... Journal of the American College of Cardiology (JACC) ...
(Date:9/30/2014)... , Sept. 30, 2014 BioStructures, ... the American Association of Tissue Banks (AATB), it ... Chief Executive Officer. Accreditation follows an ... a specially trained AATB inspector.  It establishes that ... within the facility meets or exceeds the standards ...
(Date:9/30/2014)... New York , September 30, 2014 ... - Global Industry Analysis, Market Size, Share, Growth and ... is expected to be worth USD 20.8 billion in ... billion in 2017, growing at a CAGR of 7.3% ... fundamental elements needed for various health purposes, especially to ...
Breaking Medicine Technology:New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Biostructures, LLC Earns AATB Accreditation 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4
Straight shafts with 16 mm long platform. Lengthwise serrated jaws with cross serrated tips. Serrated handle with polished finish. Platform: 2.4 mm wide....
Straight shafts with 15 mm long jaws. Serrated handle with polished finish. Smooth jaws....
Straight shafts with 6.5 mm tying platform. Crisscross serrated 1mm tips. Scalloped handle with dull finish....
Smooth tip forceps allow the surgeon to manipulate and smooth the corneal flap in Lasik procedures. Tip angled 10 mm from tip. Manufactured in titanium....
Medicine Products: